BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 266970)

  • 1. Phytohemagglutinin skin tests in cancer patients.
    Zuckerman KS; LoBuglio AF
    Cancer; 1977 Jun; 39(6):2355-61. PubMed ID: 266970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
    Burdick JF; Wells SA; Herberman RB
    Surg Gynecol Obstet; 1975 Nov; 141(5):779-94. PubMed ID: 128144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
    Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM
    Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytohemagglutinin (PHA) skin test in patients with sarcoidosis.
    Kataria YP; LoBuglio AF; Helentjaris T; Bromberg PA
    Am Rev Respir Dis; 1975 Oct; 112(4):575-8. PubMed ID: 1200490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed hypersensitivity skin reactions to antigens on human tumors.
    Herberman RB
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1469-73. PubMed ID: 4609389
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro lymphocyte dysfunction in Hodgkin's disease.
    Graze PR; Perlin E; Royston I
    J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hypersensitivity and lymphocytic transformation in patients with Hodgkin's disease and granulomas.
    Pick AI; Duer D; Kessler H; Kenan Z; Weiss H; Topilski M
    Cancer; 1978 Jun; 41(6):2192-6. PubMed ID: 657087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin tests in childhood lymphoma and neuroblastoma.
    Gasparini M; Bardare M; Fossati Bellani F
    Tumori; 1976; 62(4):429-34. PubMed ID: 1020049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
    Steele R; Han T
    Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of radiation therapy on mumps-delayed type hypersensitivity reaction in lymphoma and carcinoma patients.
    Check JH; Damsker JI; Brady LW; O'Neill EA
    Cancer; 1973 Sep; 32(3):580-4. PubMed ID: 4726964
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune function of successfully treated lymphoma patients.
    King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocompetence, immunodeficiency and prognosis in cancer.
    Hersh EM; Gutterman JU; Mavligit GM; Mountain CW; McBride CM; Brugess MA; Lurie PM; Zelen M; Takita H; Vincent RG
    Ann N Y Acad Sci; 1976; 276():386-406. PubMed ID: 800324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro assays of cellular immunity to human tumor antigens.
    Herberman RB
    Fed Proc; 1973 Feb; 32(2):160-4. PubMed ID: 4120197
    [No Abstract]   [Full Text] [Related]  

  • 16. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Transfer of cell-mediated skin reactivity with "immune" RNA in Hodgkin's disease and other neoplastic diseases.
    Han T
    Cancer; 1974 Feb; 33(2):497-502. PubMed ID: 4130298
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte reactivity in healthy subjects and cancer patients.
    Haasz R; Robinson E
    Acta Haematol; 1977; 57(6):331-8. PubMed ID: 407762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival.
    Young RC; Corder MP; Berard CW; DeVita VT
    Arch Intern Med; 1973 Mar; 131(3):446-54. PubMed ID: 4574227
    [No Abstract]   [Full Text] [Related]  

  • 20. T and B lymphocytes in non-Hodgkin's lymphoma: a comparison of tumor-derived cells and peripheral blood lymphocytes.
    Noguchi S; Bukowski R; Deodhar S; Hewlett JS
    Cancer; 1976 May; 37(5):2247-54. PubMed ID: 1083288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.